Radioiodine Treatment of Thyroid Carcinoma—A Report prepared

An informal discussion of the radioiodine treatment of thyroid carcinoma took place at University College Hospital Medical School on Saturday, July 29, 1950. The following were present:

Dr. Blomfield, Graves' Institute of Radiotherapy, Sheffield; Dr. Brownell, Massachusetts General Hospital, Boston; Dr. Cipriani (with Dr. Felstead), Atomic Energy Project, Chalk River; Dr. Farmer, Royal Victoria Infirmary, Newcastle; Dr. Gilbert, Holt Radium Institute, Manchester; Dr. Green, Meyerstein Institute of Radiotherapy, Middle-sex Hospital, London; Dr. Hilton, Department of Radiotherapy, University College Hospital, London; Dr. Marinelli, Argonne National Laboratory, Chicago; Dr. Miller, Graves' Institute of Radiotherapy, Sheffield; Dr. Müller, Universitats-Frauenklinik, Zurich; Dr. Myant, Department of Clinical Research, University College Hospital, London; Dr. Myers, Department of Medicine, Ohio State University, Columbus; Dr. Nickson, Memorial Hospital, New York; Dr. Pochin, Department of Clinical Research, University College Hospital, London; Dr. Quimby, Department of Radiology, Columbia University, New York; Mr. Quinton, Queen Elizabeth Hospital, Birmingham; Dr. Roswit, Veterans' Administration Hospital, Bronx, New York; Dr. Seidlin, Montefiore Hospital, New York; Dr. Sinclair, Royal Cancer Hospital, London; Mr. Stewart, Hammersmith Hospital, London; Mr. Thurgar, Royal Victoria Infirmary, Newcastle; Dr. Tubiana, Groupe Hospitalier Necker, Enfants Malades, Paris; Dr. Tudway, Bristol Royal Hospital, Bristol; Dr. Walton, Royal Cancer Hospital, London; Dr. Warren, New England Deaconess Hospital, Boston; Dr. Warrington, Holt Radium Institute, Manchester.

A preliminary count showed that this group represented an experience of about 300 cases of thyroid carcinoma investigated, and rather over 100 cases treated with radio-iodine.